GM
Last reporting period 30 Jun, 2024
Updated 18 Sep, 2024
Last price
—
Market cap $B
16.818
Exchange
XCSE - Nasdaq Copenhagen A/S
9.8
Last period Current ratio
-42%
Current ratio has decreased in 5 years
What is Current ratio ?
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
See also Genmab
Company Analysis
GMAB.CO valuation, rating, competitors, insights and company profile
Eyestock Rating
GMAB.CO financial analysis by Eyestock methodology
Valuation
GMAB.CO valuation using historical relative method
Statements
GMAB.CO Income Statements, Balance Sheet and Cash Flow Statements
Dividends
GMAB.CO dividend yield and annual dividend
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
Genmab`s Current ratio for the last twelve months ended 2024-06-30 is 9.8
